NCT05190705 2026-05-20Loncastuximab Tesirine in WMDana-Farber Cancer InstitutePhase 2 Active not recruiting21 enrolled
NCT01813227 2026-04-03A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531Hackensack Meridian HealthPhase 2 Completed7 enrolled 10 charts